Costs prompt changes in drug use for cancer survivorsFebruary 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Immunotherapy receives fast track designationFebruary 22, 2017Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Walking can benefit advanced cancer patientsFebruary 19, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
Proximity to oil, gas wells linked to ALLFebruary 16, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin Lymphoma
Styrene exposure linked to myeloid leukemia, HLFebruary 16, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLHodgkin LymphomaCMLAggressive Lymphomas
Drug produces high response rates in AITLFebruary 16, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Cancer survivors report pros and cons of telehealthFebruary 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
How EBV causes lymphoma, other cancersFebruary 14, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
G-CSF could prevent infertility in cancer patientsFebruary 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsAggressive Lymphomas
Team creates online database of cancer mutationsFebruary 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive Lymphomas
Investigators report new risk loci for CLLFebruary 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Obinutuzumab approved to treat FL in CanadaFebruary 8, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
NCCN releases patient guidelines for WM/LPLFebruary 7, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Company reports third death in SL-401 trialFebruary 4, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
OS is worse with refractory vs relapsed PTCLFebruary 3, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma